回肠转位手术对猪血糖及肠激素的调节作用

Effects of ileal transposition on the regulation of glycemia and intestinal hormones in a porcine model

  • 摘要: 目的:探讨回肠转位手术对猪血糖代谢的调节作用、肠激素水平及体质量的影响。
    方法:将19只Yorkshire猪按随机数字表法分为回肠转位手术组(10只)及手术对照组(9只),分别实施回肠转位手术及对照手术。术前及术后1~4周,每周测定体质量;术前、术后2周、术后4周静脉采血检测WBC、RBC、 红细胞压积(HCT)、Hb等实验室生化指标;术前、术后第4周经十二指肠灌注行葡萄糖耐量实验(DGTT),记录各时相点血糖值,绘制曲线并计算曲线下面积;DGTT中,分别采集0 min和40 min静脉血样检测血清胰高血糖素样肽1(GLP1)。实验数据采用Mann Whitney U 非参数检验。
    结果:结果:回肠转位手术组和手术对照组Yorkshire猪术后1、2、3、4周体质量分别为29.5、30.3、31.6、32.1 kg和26.1、28.9、30.5、34.1 kg,两组Yorkshire猪术后2、3、4周体质量均分别较术后1周有明显增长(Z回肠转位手术组=2.11,2.21,2.33,Z手术对照组=2.13,2.18,2.27,P<0.05);术后4周两组Yorkshire猪体质量比较,差异无统计学意义(Z=0.45,P>0.05)。回肠转位手术组Yorkshire猪术后2周和4周WBC、RBC、HCT、Hb分别为(19.9±3.2)×109/L、(5.40±0.21)×1012/L、(29.8±1.4)×109/L、(84±4)g/L和(23.3±2.5)×109/L、(5.30±0.22)×1012/L、(30.1±1.6)×109/L、(85±4)g/L,术前分别为(16.7±1.6)×109/L、(5.80±0.22)×1012/L、(33.1±1.3)×109/L、(92±4)g/L,术后与术前各指标比较,差异无统计学意义(ZWBC=1.24,1.54,ZRBC=0.84,0.88,ZHCT=0.95,0.83,ZHb=1.25,1.17,P>0.05);手术对照组Yorkshire猪术后2周和4周上述指标分别为(18.7±2.3)×109/L、(5.50±0.21)×1012/L、(33.3±1.1)×109/L、(89±4)g/L和(16.2±0.7)×109/L、(5.60±0.16)×1012/L、(34.5±1.6)×109/L、(89±4)g/L,与术前相应指标(检测值同回肠转位手术组术前指标)比较,差异无统计意义(ZWBC=1.04,0.36,ZRBC=0.78,0.43,ZHCT=0.22,0.42,ZHb=0.78,0.79,P>0.05)。回肠转位手术组Yorkshire猪血糖峰值为(10.6±2.9)mmol/L,较术前的(13.5±2.6)mmol/L和手术对照组的(13.3±3.7)mmol/L显著降低(Z=2.31,2.30,P<0.05);回肠转位手术组Yorkshire猪血糖达峰值时间为(90±11)min,较手术对照组的(50±5)min明显延迟(Z=2.29,P<0.05);回肠转位手术组Yorkshire猪糖耐量曲线下面积为(1569±546)mmol/L×min,明显低于术前基线水平(1938±873)mmol/L×min(Z=2.26,P<0.05)。术后第4周,葡萄糖灌注后40 min回肠转位手术组Yorkshire猪血浆GLP1水平为(10.0±1.6)μg/L,明显高于手术对照组的(4.3±1.7)μg/L(Z=2.12,P<0.05)。结论:在Yorkshire猪大型哺乳类动物模型中, 回肠转位手术可以有效改善其血糖代谢,并伴有肠激素GLP 1水平的升高,且手术本身并不导致机体体质量的下降。

     

    Abstract: Objective:To investigate the effects of ileal transposition on the levels of glycemia and intestinal hormones in a porcine model.
    Methods:Nineteen Yorkshire young pigs were randomly divided into ileal transposition group (10 pigs) and sham operation group (9 pigs). The body weights of the pigs were recorded before operation and on postoperative week 1, 2, 3 and 4, and the routine biochemical indicators such as white blood 〖HJ*4〗cell (WBC), red blood cell (RBC), hematocrit (HCT), hemoglobin (Hb) were determined before operation and on postoperative week 2 and 4. Duodenum glucose tolerance test (DGTT) was performed before operation and on postoperative week 4. Blood samples at different time points were collected for glucose measurement, and the area under curve (AUC) was calculated. The levels of glucagon like peptide 〖KG*9〗1 (GLP 〖KG*9〗1) were detected at 0 minute and 40 minutes in the DGTT. All data were analyzed using the Mann Whitney U non parametric test.
    Results The body weights of the pigs on postoperative week 1, 2, 3 and 4 were 29.5 kg, 30.3 kg, 31.6 kg, 32.1 kg in the ileal transposition group, and 26.1 kg, 28.9 kg, 30.5 kg, 34.1 kg in the sham operation group. The body weights at postoperative week 2, 3, 4 were significantly higher than those at postoperative week 1 in the 2 groups ( Z ileal transposition group = 2.11, 2.21, 2.33, Z sham operation group =2.13, 2.18, 2.27, P <0.05). There was no significant difference in the body weights in postoperative week 4 between the 2 groups ( Z=0.45, P >0.05). The levels of WBC, RBC, HCT, Hb were (19.9±3.2)×10 9/L, (5.40±0.21)×10 12 /L, (29.8±1.4)×10 9/L, (84±4)g/L at postoperative week 2, and (23.3±2.5)×10 9/L, (5.30±0.22)×10 12 /L, (30.1±1.6)×10 9/L, (85±4)g/L at postoperative week 4, and (16.7±1.6)×10 9/L, (5.80±0.22)×10 12 /L, (33.1± 1.3) ×10 9/L, (92±4)g/L before operation in the ileal transposition group. There were no significant differences in the 4 indexes before and after operation ( Z WBC =1.24, 1.54, Z RBC =0.84, 0.88, Z HCT =0.95, 0.83, Z Hb =1.25, 1.17, P >0.05). The levels of WBC, RBC, HCT, Hb were (18.7±2.3)×10 9/L, (5.50±0.21)×10 12 /L, (33.3±1.1)×10 9/L, (89±4)g/L at postoperative week 2, and (16.2±0.7)×10 9/L, (5.60± 0.16) ×10 12 /L, (34.5±1.6)×10 9/L, (89±4)g/L at postoperative week 4, there were no significant differences in the 4 indexes before and after operation ( Z WBC = 1.04, 0.36, Z RBC =0.78, 0.43, Z HCT =0.22, 0.42, Z Hb =0.78, 0.79, P >0.05). The peak level of glycemia of the ileal transposition group was (10.6±2.9)mmol/L, which was significantly lower than (13.5±2.6)mmol/L before operation and (13.3±3.7)mmol/L of the sham operation group ( Z=2.31, 2.30, P <0.05). The glycemic peak time of the ileal transposition group was (90±11)minutes, which was significantly delayed when compared with (50±5)minutes of the sham operation group ( Z=2.29, P <0.05). The AUC of the ileal transposition group was (1569±546)mmol/L×minutes, which were significantly lower than (1938±873)mmol/L×minutes ( Z=2.26, P <0.05). At postoperative week 4, the GLP 〖KG*9〗1 level of the ileal transposition group was (10.0±1.6)μg/L, which was significantly higher than (4.3± 1.7)μg/L at 40 minutes after glucose administration ( Z=2.12, P <0.05).
    Conclusion:Ileal transposition could effectively improve the glycemia metabolism and elevate the level of intestinal hormone GLP 〖KG*9〗1 in large mammals, meanwhile, Ileal transposition itself will not lead to body weight loss.

     

/

返回文章
返回